Back to News
Market Impact: 0.25
The Insides Company franchit une nouvelle étape vers le remboursement de son dispositif médical The Insides System® en France
Source: globenewswire.com
Healthcare & BiotechRegulation & LegislationCompany Fundamentals
La Haute Autorité de Santé émet un avis favorable à l’inscription du The Insides System sur la LPPR, franchissant une étape vers une prise en charge pérenne des patients atteints d’insuffisance intestinale de type II. L’annonce réduit le risque de couverture/éligibilité au remboursement, ce qui peut améliorer la visibilité commerciale et l’adoption du produit.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Indonesia stocks suffer biggest daily slump since 1998 as MSCI weighs downgrade
- The IPO drought is driving private equity-owned companies to the debt market to pay investors
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- FDA approves Enspryng for thyroid eye disease treatment
- Giant Taiwanese chipmaker TSMC confirms it’s in talks with Elon Musk to join ‘Terafab’ complex in Texas: ‘The AI market continues to be very strong’
- Hybe shares jump 10% as K-pop sensation BTS' tour lifts earnings hopes